| __timestamp | Bausch Health Companies Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 94231000 |
| Thursday, January 1, 2015 | 582800000 | 146394000 |
| Friday, January 1, 2016 | 455000000 | 188272000 |
| Sunday, January 1, 2017 | 366000000 | 166707000 |
| Monday, January 1, 2018 | 414000000 | 401843000 |
| Tuesday, January 1, 2019 | 471000000 | 560909000 |
| Wednesday, January 1, 2020 | 452000000 | 722343000 |
| Friday, January 1, 2021 | 465000000 | 771182000 |
| Saturday, January 1, 2022 | 529000000 | 877090000 |
| Sunday, January 1, 2023 | 604000000 | 877387000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Bausch Health Companies Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Sarepta Therapeutics, Inc. has shown a remarkable increase in R&D expenses, growing by approximately 830%, from $94 million to nearly $877 million. This surge underscores Sarepta's aggressive pursuit of cutting-edge therapies. In contrast, Bausch Health Companies Inc. has maintained a more stable R&D budget, with a 145% increase over the same period, reaching $604 million in 2023.
These trends highlight Sarepta's strategic focus on innovation, potentially positioning it as a leader in the biotech sector. Meanwhile, Bausch's steady investment reflects a balanced approach to sustaining its market presence.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated